It is studied in experimental models for effects on body composition, lipolysis, and IGF-1 modulation without significant cortisol or prolactin elevation
Cyanocobalamin | Drugs BNF NICE
Adduct concentrations varied according to the degree of exposure
Medical and Life Sciences
Preclinical and some early clinical research has examined whether replenishment strategies affect neurological outcomes
People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications